Impact of angiotensin-converting enzyme inhibitors or receptor blockers on post-ICU discharge outcome in patients with acute kidney injury
Matthieu Legrand(University of California, San Francisco), Romain Sonneville(Université Claude Bernard Lyon 1), Matthieu Resche‐Rigon(Inserm), Marie-Céline Fournier(Inserm), Qin Lü(Wenzhou Medical University), Samir Jaber(Centre National de la Recherche Scientifique), Alain Cariou(Délégation Paris 5), Étienne Gayat(Inserm), Michaël Darmon(Université Jean Monnet), Xavier Monnet(Université Paris-Sud), Benjamin G. Chousterman(Inserm), Alexandre Mebazaa, Marc Léone(Aix-Marseille Université), Jean‐Yves Lefrant(Université de Montpellier), Antoine Vieillard‐Baron(Assistance Publique – Hôpitaux de Paris), Nicolas Deye(Inserm), Pierre François Laterre(Université Paris-Sud), Alexa Hollinger(Aalborg University), Bertrand Guidet(Sorbonne Université)
Cited by 92
Related Papers
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2023|2.2k
Cardio-renal syndromes: report from the consensus conference of the Acute Dialysis Quality Initiative
|European Heart Journal|2009|1.1k
Hypothermia versus Normothermia after Out-of-Hospital Cardiac Arrest
|New England Journal of Medicine|2021|979
ESICM guidelines on acute respiratory distress syndrome: definition, phenotyping and respiratory support strategies
|Intensive Care Medicine|2023|855
Type 2 Diabetes Mellitus and Heart Failure: A Position Statement from the Heart Failure Association of the European Society of Cardiology
|European Journal of Heart Failure|2018|714